Letrozole is an active drug ingredient that’s available as a generic medication. It comes as oral tablets that you’ll swallow. Letrozole is a hormone therapy for breast cancer. Read on to ...

APP will market Letrozole in 2.5 mg tablets. According to IMS data, sales of the branded product in the United States were approximately $619.4 million, with approximately 1,775,000 bottles of 30 ...

Novartis), an antineo­plastic agent indicated for the treatment of breast cancer. Letrozole 2.5mg is available in bottles of 30 tablets. For more information call (888) 838-2872.

Letrozole Tablets are the generic version of Novartis' Femara® Tablets, an adjuvant treatment for postmenopausal women with hormone receptor-positive early stage breast cancer.

(letrozole tablets) for the first-line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer. Most ...

Co announces it has received tentative approval from the FDA for its Abbreviated New Drug Application for Letrozole Tablets U.S.P, 2.5 mg.

The aromatase inhibitor letrozole, by suppressing estrogen production, might improve the outcome after the discontinuation of tamoxifen therapy. A total of 5187 women were enrolled (median follow ...